Coronary Microvascular Dysfunction and Cardiovascular Risk in Obese Patients

被引:145
作者
Bajaj, Navkaranbir S. [1 ,2 ]
Osborne, Michael T. [1 ,2 ,3 ,4 ]
Gupta, Ankur [1 ,2 ]
Tavakkoli, Ali [5 ]
Bravo, Paco E. [1 ,2 ]
Vita, Tomas [1 ,2 ]
Bibbo, Courtney F. [1 ,2 ]
Hainer, Jon [1 ,2 ]
Dorbala, Sharmila [1 ,2 ,6 ]
Blankstein, Ron [1 ,2 ,6 ]
Bhatt, Deepak L. [6 ]
Di Carli, Marcelo F. [1 ,2 ,6 ]
Taqueti, Viviany R. [1 ,2 ,6 ]
机构
[1] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Cardiovasc Imaging Program, Boston, MA USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Cardiovasc Imaging Program, Boston, MA USA
[3] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Cardiac MR PET CT Program, Boston, MA USA
[4] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Cardiac MR PET CT Program, Boston, MA USA
[5] Harvard Med Sch, Brigham & Womens Hosp, Ctr Weight Management & Metab Surg, Boston, MA USA
[6] Harvard Med Sch, Brigham & Womens Hosp, Heart & Vasc Ctr, Boston, MA USA
基金
美国国家卫生研究院;
关键词
bariatric surgery; body mass index; coronary microvascular dysfunction; obesity; prognosis; AMERICAN-HEART-ASSOCIATION; INTENSIVE MEDICAL THERAPY; MYOCARDIAL BLOOD-FLOW; BARIATRIC SURGERY; CIRCULATORY FUNCTION; PRACTICE GUIDELINES; ARTERY-DISEASE; WEIGHT-LOSS; RESERVE; INFLAMMATION;
D O I
10.1016/j.jacc.2018.05.049
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Besides body mass index (BMI), other discriminators of cardiovascular risk are needed in obese patients, who may or may not undergo consideration for bariatric surgery. Coronary microvascular dysfunction (CMD), defined as impaired coronary flow reserve (CFR) in the absence of flow-limiting coronary artery disease, identifies patients at risk for adverse events independently of traditional risk factors. OBJECTIVES The study sought to investigate the relationship among obesity, CMD, and adverse outcomes. METHODS Consecutive patients undergoing evaluation for coronary artery disease with cardiac stress positron emission tomography demonstrating normal perfusion (N = 827) were followed for median 5.6 years for events, including death and hospitalization for myocardial infarction or heart failure. RESULTS An inverted independent J-shaped relationship was observed between BMI and CFR, such that in obese patients CFR decreased linearly with increasing BMI (adjusted p < 0.0001). In adjusted analyses, CFR but not BMI remained independently associated with events (for a 1-U decrease in CFR, adjusted hazard ratio: 1.95; 95% confidence interval: 1.41 to 2.69; p < 0.001; for a 10-U increase in BMI, adjusted hazard ratio: 1.20; 95% confidence interval: 0.95 to 1.50; p = 0.125) and improved model discrimination (C-index 0.71 to 0.74). In obese patients, individuals with impaired CFR demonstrated a higher adjusted rate of events (5.7% vs. 2.6%; p = 0.002), even in those not currently meeting indications for bariatric surgery (6.4% vs. 2.6%; p = 0.04). CONCLUSIONS In patients referred for testing, CMD was independently associated with elevated BMI and adverse outcomes, and was a better discriminator of risk than BMI and traditional risk factors. CFR may facilitate management of obese patients beyond currently used markers of risk. (c) 2018 by the American College of Cardiology Foundation.
引用
收藏
页码:707 / 717
页数:11
相关论文
共 40 条
[1]  
Heymsfield S.B., Wadden T.A., Mechanisms, pathophysiology, and management of obesity, N Engl J Med, 376, pp. 254-266, (2017)
[2]  
Ortega F.B., Lavie C.J., Blair S.N., Obesity and cardiovascular disease, Circ Res, 118, pp. 1752-1770, (2016)
[3]  
Stefan N., Haring H.U., Hu F.B., Schulze M.B., Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications, Lancet Diabetes Endocrinol, 1, pp. 152-162, (2013)
[4]  
Kim J., Eisenberg D., Azagury D., Rogers A., Campos G.M., American Society for Metabolic and Bariatric Surgery position statement on long-term survival benefit after metabolic and bariatric surgery, Surg Obes Relat Dis, 12, pp. 453-459, (2016)
[5]  
Schauer P.R., Kashyap S.R., Wolski K., Et al., Bariatric surgery versus intensive medical therapy in obese patients with diabetes, N Engl J Med, 366, pp. 1567-1576, (2012)
[6]  
Pareek M., Schauer P.R., Kaplan L.M., Leiter L.A., Rubino F., Bhatt D.L., Metabolic surgery: weight loss, diabetes, and beyond, J Am Coll Cardiol, 71, pp. 670-687, (2018)
[7]  
Taqueti V.R., Myocardial perfusion imaging in extreme obesity: leveraging modern technologies to meet a modern challenge, J Nucl Cardiol, (2017)
[8]  
Motivala A.A., Rose P.A., Kim H.M., Et al., Cardiovascular risk, obesity, and myocardial blood flow in postmenopausal women, J Nucl Cardiol, 15, pp. 510-517, (2008)
[9]  
Schindler T.H., Cardenas J., Prior J.O., Et al., Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function, J Am Coll Cardiol, 47, pp. 1188-1195, (2006)
[10]  
Tona F., Serra R., Di Ascenzo L., Et al., Systemic inflammation is related to coronary microvascular dysfunction in obese patients without obstructive coronary disease, Nutr Metab Cardiovasc Dis, 24, pp. 447-453, (2014)